Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.6701
-0.0239 (-3.44%)
At close: May 8, 2026, 4:00 PM EDT
0.6750
+0.0049 (0.73%)
After-hours: May 8, 2026, 7:11 PM EDT
Hoth Therapeutics Employees
As of December 31, 2025, Hoth Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$4,156,434
Market Cap
12.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2024 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2023 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2022 | 3 | -2 | -40.00% | 2 | 1 |
| Dec 31, 2021 | 5 | 1 | 25.00% | 4 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Passage Bio | 24 |
| Moleculin Biotech | 17 |
| Cellectar Biosciences | 11 |
| Intensity Therapeutics | 7 |
| Phio Pharmaceuticals | 6 |
| Jupiter Neurosciences | 5 |
| Cyclerion Therapeutics | 1 |
| GT Biopharma | 1 |
HOTH News
- 4 days ago - Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients - PRNewsWire
- 25 days ago - Hoth Therapeutics reports results from HT-VA study - TheFly
- 25 days ago - Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide - PRNewsWire
- 26 days ago - Hoth Therapeutics reports positive HT-VA CRADA data - TheFly
- 26 days ago - Hoth Therapeutics up 52% at $0.78 per share after HT-VA data - TheFly
- 5 weeks ago - Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering - PRNewsWire
- 5 weeks ago - Hoth Therapeutics announces $2M registered direct offering - TheFly
- 5 weeks ago - Hoth Therapeutics Announces $2.0 Million Registered Direct Offering - PRNewsWire